SODIUM ZIRCONIUM CYCLOSILICATE (Lokelma®)

Clinical Indication

Acute hyperkalaemia and Chronic hyperkalaemia in Heart Failure

Comments

FIRST CHOICE Treatment of acute hyperkalaemia, see local ED pathway.

Chronic hyperkalaemia within heart failure.

Use in line with NICE TA 599

Date of classification

August 2024

Red

Medicines which should be prescribed only in a specialist setting usually within a secondary or tertiary care service. NB: Some highly specialised RED medicines e.g. injectable treatments for cancer are not included on the LLR APC website list.